EDEN PRAIRIE, Minn., May 10, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ...

(RTTNews) - NeuroOne Medical Technologies Corp. (NMTC) has submitted a special 510(k) to the FDA for its sEEG electrode to extend the duration of use from less than 24 hours to less than 30 day use.

NeuroOne Medical Technologies NMTC has submitted a special 510(k) to the U.S. Food and Drug Administration (FDA) for its sEEG electrode to extend the duration of use from less than 24 hours to less ...

Persistence has paid off for NeuroOne Medical Technologies, a company that develops electrode technology for diagnostic brain mapping procedures. NeuroOne's Evo sEEG system had previously been FDA ...

Peer-Reviewed Case Series Supports Safe Integration into Existing Stereotactic Workflow, Bedside Treatment Capability, and Reductions in Seizure Burden in Patients with Drug-Resistant Epilepsy* The ...

The Evo stereoelectroencephalography (sEEG) electrode is placed on or in the brain to record, monitor and stimulate brain signals in patients with neurological conditions like Parkinson’s disease and ...

Typically, a patient undergoing epilepsy surgery that requires an electrode to be put in the brain or spine has to endure a large incision or even having the top of their skull cut open to accommodate ...

MANHASSET, N.Y.--(BUSINESS WIRE)--In a first-in-human study, researchers at The Feinstein Institutes for Medical Research elicited the sense of touch through a minimally-invasive electrode brain ...

EDEN PRAIRIE, Minn., July 12, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care ...